Our study provides the groundwork for further exploring the predominant, biologically relevant folding pattern of the CARD11 G4 structure and how targeting this structure impacts BCR signaling for developing new therapeutic strategies in BCR-dependent lymphomas. Here, BCR is linked to lymphoma.